Home › Funds › MARTINGALE ASSET MANAGEMENT L P › GILD

MARTINGALE ASSET MANAGEMENT L P position in GILD

GILEAD SCIENCES INC · Health Care

MARTINGALE ASSET MANAGEMENT L P reported holding 173,001 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$25.8M, representing 0.64% of its reported portfolio and ranking #33 among its reported holdings. MARTINGALE ASSET MANAGEMENT L P has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)173.00K sh
Reported value held$25.79M
Portfolio Weight0.64%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How MARTINGALE ASSET MANAGEMENT L P's GILD position evolved

MARTINGALE ASSET MANAGEMENT L P first disclosed a stake in GILD in Q3 2023 at 362,529 shares (US$27.2M). The position peaked in Q4 2023 at 338,027 shares, worth US$27.4M. Across 13 filings, MARTINGALE ASSET MANAGEMENT L P increased the stake 2 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 173,001 shares valued at US$25.8M — a reduction of -8,878 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 362.53K $27.17M New
Q4 2023 338.03K $27.38M Reduce
Q1 2024 314.89K $23.07M Reduce
Q2 2024 303.52K $20.82M Reduce
Q3 2024 255.51K $21.42M Reduce
Q4 2024 229.50K $21.20M Reduce
Q1 2025 196.68K $22.04M Reduce
Q2 2025 194.24K $21.54M Reduce
Q3 2025 172.77K $19.18M Reduce
Q4 2025 193.92K $23.80M Add
Q1 2026 179.46K $25.01M Reduce
Q2 2026 181.88K $22.98M Add
Q3 2026 173.00K $25.79M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has MARTINGALE ASSET MANAGEMENT L P held GILD?

MARTINGALE ASSET MANAGEMENT L P has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is MARTINGALE ASSET MANAGEMENT L P's current position in GILD?

As of Q3 2026, MARTINGALE ASSET MANAGEMENT L P holds 173.00K shares of GILD (GILEAD SCIENCES INC), valued at $25.79M, representing 0.64% of its reported portfolio and ranking #33.

Has MARTINGALE ASSET MANAGEMENT L P been buying or selling GILD?

In the latest 13F filing (Q3 2026), MARTINGALE ASSET MANAGEMENT L P reduced its position in GILD. The position peaked in Q4 2023 at 338.03K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.